Alternatives to Oxford Science Enterprises

An accelerator program for life science startups.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Unleashing the power of genomics at scale for biological advances and human health.

A venture capital firm focused on deeptech innovation.

AI-driven digital twin of embryo development for cell-based therapies.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Dot Compliance provides an AI-powered eQMS for life sciences companies to accelerate product delivery and reduce costs.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Advanced infectious disease diagnostics

Develops a platform for adaptive clinical trial design and closed-loop execution.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

Accelerating the development of breakthrough new medicines and medical technologies.

Venture capital company supporting innovative Bavarian startups and technology companies with growth capital.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered insights platform for life sciences and biotech workflows.